Terry L. Lierman - Mar 13, 2024 Form 4 Insider Report for IGC Pharma, Inc. (IGC)

Role
Director
Signature
/s/ Terry L. Lierman
Stock symbol
IGC
Transactions as of
Mar 13, 2024
Transactions value $
$0
Form type
4
Date filed
3/15/2024, 05:34 PM
Previous filing
Mar 12, 2024

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction IGC OPTIONS Award $0 +150K $0.00 150K Mar 13, 2024 Common Stock 150K $0.30 Direct F1, F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Represents 150,000 options to buy shares of common stock, 50,000 vesting immediately and 100,000 subject to vesting over two years in equal parts starting 2025, as per the IGC Board of Directors Agreement with Mr. Lierman.
F2 Exercisable in equal amounts on March 2024, 2025 & 2026.